Toward molecular imaging using spectral photon-counting computed tomography?

Molecular imaging is a valuable tool in drug discovery and development, early screening and diagnosis of diseases, and therapy assessment among others. Although many different imaging modalities are in use today, molecular imaging with computed tomography (CT) is still challenging owing to its low s...

Full description

Saved in:
Bibliographic Details
Main Authors: Sawall, Stefan (Author) , Amato, Carlo (Author) , Klein, Laura (Author) , Wehrse, Eckhard (Author) , Maier, Joscha (Author) , Kachelrieß, Marc (Author)
Format: Article (Journal)
Language:English
Published: August 2021
In: Current opinion in chemical biology
Year: 2021, Volume: 63, Pages: 163-170
ISSN:1879-0402
DOI:10.1016/j.cbpa.2021.04.002
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.cbpa.2021.04.002
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S136759312100048X
Get full text
Author Notes:Stefan Sawall, Carlo Amato, Laura Klein, Eckhard Wehrse, Joscha Maier and Marc Kachelrieß
Description
Summary:Molecular imaging is a valuable tool in drug discovery and development, early screening and diagnosis of diseases, and therapy assessment among others. Although many different imaging modalities are in use today, molecular imaging with computed tomography (CT) is still challenging owing to its low sensitivity and soft tissue contrast compared with other modalities. Recent technical advances, particularly the introduction of spectral photon-counting detectors, might allow overcoming these challenges. Herein, the fundamentals and recent advances in CT relevant to molecular imaging are reviewed and potential future preclinical and clinical applications are highlighted. The review concludes with a discussion of potential future advancements of CT for molecular imaging.
Item Description:Gesehen am 06.10.2021
Physical Description:Online Resource
ISSN:1879-0402
DOI:10.1016/j.cbpa.2021.04.002